You are here: Industry Insights > Beroni

News List

Beroni, tella Sign MoU for Cancer Immunotherapy Treatment contractpharma
May 31, 2021
Beroni Group, an Australia-based biopharmaceutical enterprise, has signed a Memorandum of Understanding with tella, Inc. to collaborate in the field of immunotherapy for cancer treatment.
Beroni Acquires Majority Interest in PENAO americanpharmaceuticalreview
February 08, 2021
Beroni Group has completed its majority acquisition of the Sydney-based anti-cancer drug development company, PENAO Pty Ltd. As a result of this acquisition, Beroni now owns 60% of PENAO Pty Ltd’s shares.
SARS-CoV-2 Antigen Test Kit Receives CE Certification americanpharmaceuticalreview
December 22, 2020
Beroni Group has received notification from its European Authorized Representative, CMC Medical Devices & Drugs SL, that its newly developed SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) complies with the applicable essential requirements of the ...
Beroni Signs Agreement with CDMO Genscript Biotech contractpharma
August 13, 2020
To conduct further study to develop nanobody-based medical solution for COVID-19.
Beroni Successfully Constructs Purified Nanobodies for COVID-19 Detection and Treatment americanpharmaceuticalreview
August 07, 2020
Beroni Group has provided an update on the development of the previously announced potential medical solution utilizing nanobody technology for both detection and treatment of COVID-19 in collaboration with Tianjin University in China.